IGM Biosciences, Inc. Accounts Payable
IGM Biosciences, Inc. had Accounts Payable of $2.40 million as of 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2025-07-31
- 2025-06-30: Accounts Payable, Current $2.40M.
- 2025-03-31: Accounts Payable, Current $1.30M.
- 2024-12-31: Accounts Payable, Current $983.00K.
- 2024-09-30: Accounts Payable, Current $3.54M.
| Period end | Accounts Payable, Current |
|---|---|
| 2025-06-30 | $2.40M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $1.30M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $983.00K 10-Q · filed 2025-07-31 |
| 2024-09-30 | $3.54M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $3.26M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $4.00M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $1.33M 10-K · filed 2025-03-06 |
| 2023-09-30 | $3.91M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $4.94M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $3.97M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $2.51M 10-K · filed 2024-03-07 |
| 2022-09-30 | $2.73M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $3.46M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $4.01M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $5.58M 10-K · filed 2023-03-30 |
| 2021-09-30 | $3.35M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $4.85M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $5.66M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $7.92M 10-K · filed 2022-03-29 |
| 2020-09-30 | $3.19M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $4.26M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.98M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $3.09M 10-K · filed 2021-03-30 |
| 2019-09-30 | $2.78M 10-Q · filed 2019-11-07 |
| 2018-12-31 | $164.00K 10-K · filed 2020-03-26 |